Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
BRIACELL THERAP (BCTX) had Consolidated Net Income/Loss of $-4.93M for the most recently reported fiscal year, ending 2024-07-31.
| Income Statement Financials | |
-- |
|
$-4.79M |
|
-- |
|
-- |
|
$33.33M |
|
$-33.33M |
|
$28.40M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
|
Consolidated Net Income/Loss |
$-4.93M |
$-4.93M |
|
$-33.33M |
|
$-33.25M |
|
1.10M |
|
1.10M |
|
$-4.35 |
|
$-4.35 |
|
| Balance Sheet Financials | |
$3.65M |
|
$0.39M |
|
$2.22M |
|
$5.87M |
|
$7.46M |
|
-- |
|
$1.10M |
|
$8.56M |
|
$-2.68M |
|
$-2.88M |
|
$-2.68M |
|
1.22M |
|
| Cash Flow Statement Financials | |
$-24.13M |
|
$-0.68M |
|
$4.42M |
|
$21.25M |
|
$0.86M |
|
$-20.39M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
183.68% |
|
170.95% |
|
-83.98% |
|
183.68% |
|
$-2.20 |
|
$-22.40 |
|
$-21.98 |
|